Free Trial

SG Americas Securities LLC Has $556,000 Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Pediatrix Medical Group logo with Medical background

SG Americas Securities LLC boosted its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 194.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,405 shares of the company's stock after purchasing an additional 25,343 shares during the period. SG Americas Securities LLC's holdings in Pediatrix Medical Group were worth $556,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. American Century Companies Inc. boosted its stake in shares of Pediatrix Medical Group by 628.2% in the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock valued at $22,820,000 after purchasing an additional 1,500,485 shares in the last quarter. Oberweis Asset Management Inc. bought a new position in Pediatrix Medical Group during the 4th quarter valued at about $6,122,000. Renaissance Technologies LLC boosted its position in Pediatrix Medical Group by 117.4% in the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock valued at $11,005,000 after buying an additional 453,000 shares in the last quarter. Boston Partners grew its stake in Pediatrix Medical Group by 25.2% during the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock worth $25,922,000 after buying an additional 393,600 shares during the last quarter. Finally, Nomura Holdings Inc. bought a new stake in Pediatrix Medical Group during the fourth quarter worth about $3,882,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Trading Down 0.2%

MD stock traded down $0.02 during trading on Thursday, hitting $13.61. The company had a trading volume of 567,525 shares, compared to its average volume of 732,226. The firm has a 50-day moving average price of $13.69 and a 200-day moving average price of $13.91. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of -13.47, a PEG ratio of 0.92 and a beta of 1.27.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The company had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. During the same period last year, the firm earned $0.20 EPS. The business's revenue for the quarter was down 7.4% on a year-over-year basis. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Macquarie boosted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a report on Thursday, May 8th. Truist Financial cut their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Finally, UBS Group decreased their target price on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a report on Monday, May 12th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $16.67.

Get Our Latest Stock Report on Pediatrix Medical Group

Pediatrix Medical Group Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Featured Stories

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Should You Invest $1,000 in Pediatrix Medical Group Right Now?

Before you consider Pediatrix Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pediatrix Medical Group wasn't on the list.

While Pediatrix Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines